Promising therapies for the treatment of chronic lymphocytic leukemia.
about
Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cellsReal-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
P2860
Promising therapies for the treatment of chronic lymphocytic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Promising therapies for the treatment of chronic lymphocytic leukemia.
@en
type
label
Promising therapies for the treatment of chronic lymphocytic leukemia.
@en
prefLabel
Promising therapies for the treatment of chronic lymphocytic leukemia.
@en
P2093
P2860
P1476
Promising therapies for the treatment of chronic lymphocytic leukemia.
@en
P2093
Angela Palummo
Ernesto Vigna
Fortunato Morabito
Francesca Storino
Laura De Stefano
Lucio Morabito
Mariavaleria Pellicanò
Massimo Gentile
Nadia Caruso
Sabrina Bossio
P2860
P304
P356
10.1517/13543784.2015.1021920
P407
P577
2015-03-01T00:00:00Z